Jinxin Fertility (锦欣生殖) Placement - A Familiar Name by Now and Don't Expect Extravagant Returns
A shareholder of Jinxin Fertility Co Ltd (1951 HK) is looking to raise US$100m by selling about 42m of shares or about 1.7% of total shares...
475 Views
Jinxin Fertility: Takeaways from Wuhan NDR and Yunnan Acquisition
Jinxin Fertility announced the acquisition of 19.33% indirect economic interest in two Yunnan based hospitals in China and hosted an online NDR in...
422 Views
Smartkarma North Asia Weekly: POTUS Order, Kanzhun, Angelalign, & 3 Children Policy in China
In this edition of the Smartkarma North Asia Weekly, it summarizes some of the top insights on Smartkarma in the past week covering Japan, HK...
487 Views
Hygeia Healthcare Placement - Past Deals Have Done Well but the Shares Are Now Very Expensive
Warburg Pincus aims to raise around US$216m via selling 3.2% of Hygeia Healthcare. This won’t be the first selldown by Warburg.
348 Views
China: 3rd Child Policy and 3 Beneficiaries
I take a brief look at the China's past child birth policy changes and three beneficiaries of the exposure to the new birth policy.
385 Views